In last trading session, I-Mab ADR (NASDAQ:IMAB) saw 0.51 million shares changing hands with its beta currently measuring 1.36. Company’s recent per share price level of $0.84 trading at $0.0 or 0.04% at ring of the bell on the day assigns it a market valuation of $64.69M. That closing price of IMAB’s stock is at a discount of -138.1% from its 52-week high price of $2.00 and is indicating a premium of 9.52% from its 52-week low price of $0.76. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 398.36K if we extend that period to 3-months.
For I-Mab ADR (IMAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
I-Mab ADR (NASDAQ:IMAB) trade information
Upright in the green during last session for gaining 0.04%, in the last five days IMAB remained trading in the red while hitting it’s week-highest on Friday, 03/14/25 when the stock touched $0.84 price level, adding 6.08% to its value on the day. I-Mab ADR’s shares saw a change of -1.18% in year-to-date performance and have moved -1.98% in past 5-day. I-Mab ADR (NASDAQ:IMAB) showed a performance of -12.44% in past 30-days. Number of shares sold short was 0.89 million shares which calculate 3.64 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.89% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 82.84% while estimates for its earnings growth in next 5 years are of 33.28%.
I-Mab ADR (NASDAQ:IMAB)’s Major holders
Insiders are in possession of 11.16% of company’s total shares while institution are holding 33.33 percent of that, with stock having share float percentage of 37.52%. Investors also watch the number of corporate investors in a company very closely, which is 33.33% institutions for I-Mab ADR that are currently holding shares of the company. HHLR ADVISORS, LTD. is the top institutional holder at IMAB for having 6.91 million shares of worth $11.54 million. And as of 2024-06-30, it was holding 7.7935 of the company’s outstanding shares.
The second largest institutional holder is CALIGAN PARTNERS LP, which was holding about 3.37 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.8067 of outstanding shares, having a total worth of $5.64 million.
On the other hand, abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 53.88 shares of worth $45258.0 or 0.07% of the total outstanding shares. The later fund manager was in possession of 43.74 shares on Dec 31, 2024 , making its stake of worth around $36735.0 in the company or a holder of 0.05% of company’s stock.
